Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Recommendations on data sharing in HIV drug resistance research
Seth Inzaule, Mark J. Siedner, Susan J. Little, Santiago Ávila‐Ríos, Alisen Ayitewala, Ronald J. Bosch, Vincent Cálvez, Francesca Ceccherini‐Silberstein, Charlotte Charpentier, Diane Descamps, Susan H. Eshleman, Joseph Fokam, Lisa M. Frenkel, Ravindra K. Gupta, John P A Ioannidis, Pontiano Kaleebu, Rami Kantor, Seble Kassaye, Sergei L. Kosakovsky Pond, Vinie Kouamou, Roger D. Kouyos, Daniel R. Kuritzkes, Richard Lessells, Anne‐Geneviève Marcelin, Lawrence Mbuagbaw, Brian Minalga, Nicaise Ndembi, Richard A. Neher, Roger Paredes, Deenan Pillay, Elliot Raizes, Soo‐Yon Rhee, Douglas D. Richman, Kiat Ruxrungtham, Pardis C. Sabeti, Jonathan Schapiro, Sunee Sirivichayakul, Kim Steegen, Wataru Sugiura, Gert U. van Zyl, Anne‐Mieke Vandamme, Annemarie M. J. Wensing, Joel O. Wertheim, Huldrych F. Günthard, Michael R. Jordan, Robert W. Shafer (2023). Recommendations on data sharing in HIV drug resistance research. , 20(9), DOI: https://doi.org/10.1371/journal.pmed.1004293.
Article146 days agoThe Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A
Johan Auwerx, Fátima Rodrı́guez-Barrios, Francesca Ceccherini‐Silberstein, Ana San‐Félix, Sonsoles Velázquez, De Clercq Erik, Marı́a-José Camarasa, Carlo Federico Perno, Federico Gago, Jan Balzarini (2005). The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A. , 68(3), DOI: https://doi.org/10.1124/mol.105.012351.
Article25 days agoThe amino acid N136 in HIV-1 reverse transcriptase qualifies as a target for new (NNRTI) drug design
Jan Balzarini, Johan Auwerx, Fátima Rodrı́guez-Barrios, Francesca Ceccherini‐Silberstein, Carlos Garcı́a-Aparicio, Sonsoles Velázquez, De Clercq Erik, Carlo Federico Perno, Marı́a-José Camarasa, Federico Gago (2004). The amino acid N136 in HIV-1 reverse transcriptase qualifies as a target for new (NNRTI) drug design.
Article25 days agoThe N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV‐1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti‐HIV‐1 drugs
Johan Auwerx, Joke Van Nieuwenhove, Fátima Rodrı́guez-Barrios, Sonia de Castro, Sonsoles Velázquez, Francesca Ceccherini‐Silberstein, De Clercq Erik, Marı́a-José Camarasa, Carlo Federico Perno, Federico Gago, Jan Balzarini (2005). The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV‐1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti‐HIV‐1 drugs. , 579(11), DOI: https://doi.org/10.1016/j.febslet.2005.02.077.
Article24 days agoThe Amino Acid Asn136 in HIV-1 Reverse Transcriptase (RT) Maintains Efficient Association of Both RT Subunits and Enables the Rational Design of Novel RT Inhibitors
Jan Balzarini, Johan Auwerx, Fátima Rodrı́guez-Barrios, Allel Chedad, Viktor Farkas, Francesca Ceccherini‐Silberstein, Carlos Garcı́a-Aparicio, Sonsoles Velázquez, De Clercq Erik, Carlo Federico Perno, Marı́a-José Camarasa, Federico Gago (2005). The Amino Acid Asn136 in HIV-1 Reverse Transcriptase (RT) Maintains Efficient Association of Both RT Subunits and Enables the Rational Design of Novel RT Inhibitors. , 68(1), DOI: https://doi.org/10.1124/mol.105.012435.
Article24 days ago